[PLACE OF AMITRIPTYLINE AMONG THE ANTIDEPRESSIVE AGENTS].
D000065:Accommodation, Ocular; D000639:Amitriptyline; D000928:Antidepressive Agents; D001247:Asthenia; D035843:Biomedical Research; D001714:Bipolar Disorder; D002749:Chlorprothixene; D003248:Constipation; D003681:Dehydration; D003863:Depression; D003865:Major Depressive Disorder; D004358:Drug Therapy; D006801:Humans; D007099:Imipramine; D001523:Mental Disorders; D008996:Monoamine Oxidase Inhibitors; D011618:Psychotic Disorders; D012559:Schizophrenia; D007319:Sleep Initiation and Maintenance Disorders; D013064:Speech Disorders; D013610:Tachycardia; D014116:Toxicology; D014202:Tremor; D014717:Vertigo
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D000639:Amitriptyline; D002749:Chlorprothixene; D007099:Imipramine
ACCOMMODATION, OCULAR; AMITRIPTYLINE; ASTHENIA; CHLORPROTHIXENE; CLINICAL RESEARCH; CONSTIPATION; DEHYDRATION; DEPRESSION; DRUG THERAPY; IMIPRAMINE; INSOMNIA; MONOAMINE OXIDASE INHIBITORS; PSYCHOSES, INVOLUTIONAL; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; SPEECH DISORDERS; TACHYCARDIA; TOXICOLOGIC REPORT; TREMOR; VERTIGO
PLACE DE L'AMITRIPTYLINE PARMI LES ANTI-D'EPRESSEURS.